These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 2906267

  • 1. Buspirone, 8-OH-DPAT and ipsapirone: effects on hippocampal cerebellar and sciatic fiber excitability.
    Hiner BC, Mauk MD, Peroutka SJ, Kocsis JD.
    Brain Res; 1988 Sep 27; 461(1):1-9. PubMed ID: 2906267
    [Abstract] [Full Text] [Related]

  • 2. Modulation of neuronal activity in the hippocampus by 5-hydroxytryptamine and 5-hydroxytryptamine1A selective drugs.
    Peroutka SJ, Mauk MD, Kocsis JD.
    Neuropharmacology; 1987 Sep 27; 26(2-3):139-46. PubMed ID: 2884586
    [Abstract] [Full Text] [Related]

  • 3. Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT.
    Gilbert F, Dourish CT.
    Psychopharmacology (Berl); 1987 Sep 27; 93(3):349-52. PubMed ID: 2893412
    [Abstract] [Full Text] [Related]

  • 4. Response of cerebellar Purkinje cells to serotonin and the 5-HT1A agonists 8-OH-DPAT and ipsapirone in vitro.
    Darrow EJ, Strahlendorf HK, Strahlendorf JC.
    Eur J Pharmacol; 1990 Jan 10; 175(2):145-53. PubMed ID: 1968842
    [Abstract] [Full Text] [Related]

  • 5. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E, Goldstein M, Bohmaker K.
    Mol Pharmacol; 1990 Feb 10; 37(2):231-7. PubMed ID: 1968223
    [Abstract] [Full Text] [Related]

  • 6. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R, De Vry J.
    Eur J Pharmacol; 1993 Nov 16; 249(3):341-51. PubMed ID: 7904566
    [Abstract] [Full Text] [Related]

  • 7. Inhibition by 8-hydroxy-2-(di-n-propylamino) tetralin and SM-3997, a novel anxiolytic drug, of the hippocampal rhythmical slow activity mediated by 5-hydroxytryptamine1A receptors.
    Hirose A, Tsuji R, Shimizu H, Tatsuno T, Tanaka H, Kumasaka Y, Nakamura M.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov 16; 341(1-2):8-13. PubMed ID: 1969119
    [Abstract] [Full Text] [Related]

  • 8. Effects of buspirone and ipsapirone on schedule induced polydipsia: comparison with 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and raclopride.
    Ryan CN, Evenden JL, Petterson M.
    Psychopharmacology (Berl); 1993 Nov 16; 112(1):34-44. PubMed ID: 7871008
    [Abstract] [Full Text] [Related]

  • 9. Reversal of helpless behavior in rats by putative 5-HT1A agonists.
    Giral P, Martin P, Soubrié P, Simon P.
    Biol Psychiatry; 1988 Feb 01; 23(3):237-42. PubMed ID: 2892540
    [Abstract] [Full Text] [Related]

  • 10. Buspirone, ipsapirone and 1-(2-pyrimidinyl)-piperazine decrease cold-induced thyrotropin secretion in rats.
    Broqua P, Baudrie V, Bluet-Pajot MT, Chaouloff F.
    Eur J Pharmacol; 1991 Nov 05; 204(2):141-7. PubMed ID: 1687218
    [Abstract] [Full Text] [Related]

  • 11. Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats.
    Gilbert F, Dourish CT, Brazell C, McClue S, Stahl SM.
    Psychoneuroendocrinology; 1988 Nov 05; 13(6):471-8. PubMed ID: 2907164
    [Abstract] [Full Text] [Related]

  • 12. Generalization of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and ipsapirone to yohimbine.
    Winter JC.
    Pharmacol Biochem Behav; 1988 Jan 05; 29(1):193-5. PubMed ID: 2895479
    [Abstract] [Full Text] [Related]

  • 13. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF, Lesourd M, Mocaer E, Koolhaas JM.
    J Pharmacol Exp Ther; 1999 Mar 05; 288(3):1125-33. PubMed ID: 10027850
    [Abstract] [Full Text] [Related]

  • 14. Effects of buspirone differ from those of gepirone and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on unpunished responding of pigeons.
    Barrett JE, Fleck-Kandath C, Mansbach RS.
    Pharmacol Biochem Behav; 1988 Jul 05; 30(3):723-7. PubMed ID: 2905470
    [Abstract] [Full Text] [Related]

  • 15. Blockade of the anxiolytic-like action of ipsapirone and buspirone, but not that of 8-OH-DPAT, by adrenalectomy in male rats.
    López-Rubalcava C, Cruz SL, Fernández-Guasti A.
    Psychoneuroendocrinology; 1999 May 05; 24(4):409-22. PubMed ID: 10341368
    [Abstract] [Full Text] [Related]

  • 16. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
    Söderpalm B, Hjorth S, Engel JA.
    Pharmacol Biochem Behav; 1989 Jan 05; 32(1):259-65. PubMed ID: 2567524
    [Abstract] [Full Text] [Related]

  • 17. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?
    Jolas T, Schreiber R, Laporte AM, Chastanet M, De Vry J, Glaser T, Adrien J, Hamon M.
    J Pharmacol Exp Ther; 1995 Feb 05; 272(2):920-9. PubMed ID: 7853210
    [Abstract] [Full Text] [Related]

  • 18. [3H]8-OH-DPAT labels the 5-hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatum.
    Alexander BS, Wood MD.
    J Pharm Pharmacol; 1988 Dec 05; 40(12):888-91. PubMed ID: 2907586
    [Abstract] [Full Text] [Related]

  • 19. Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone.
    Davis M, Cassella JV, Kehne JH.
    Psychopharmacology (Berl); 1988 Dec 05; 94(1):14-20. PubMed ID: 2894698
    [Abstract] [Full Text] [Related]

  • 20. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
    Moser PC, Tricklebank MD, Middlemiss DN, Mir AK, Hibert MF, Fozard JR.
    Br J Pharmacol; 1990 Feb 05; 99(2):343-9. PubMed ID: 1970269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.